- £1.21bn
- £1.69bn
- $2.32bn
- 75
- 98
- 25
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 538 | 1,108 | 1,428 | 2,598 | 2,320 |
Cost of Revenue | |||||
Gross Profit | 100 | 311 | 549 | 1,246 | 1,003 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 565 | 1,504 | 415 | 155 | 1,834 |
Operating Profit | -27.2 | -396 | 1,013 | 2,444 | 486 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -148 | -615 | 763 | 2,241 | 302 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23.6 | -456 | 426 | 1,032 | 216 |
Net Income Before Extraordinary Items | |||||
Net Income | -23.6 | -456 | 426 | 1,032 | 216 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.6 | -456 | 426 | 1,032 | 216 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.046 | -0.013 | 0.16 | 0.427 | 0.602 |
Dividends per Share |